| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 227 |
| 1 | ADALIMUMAB | 119 |
| 2 | METHOTREXATE SODIUM | 117 |
| 3 | METHOTREXATE | 109 |
| 4 | ETANERCEPT | 103 |
| 5 | INFLIXIMAB | 103 |
| 6 | FOLIC ACID | 100 |
| 7 | ACETAMINOPHEN | 96 |
| 8 | ETONOGESTREL AND ETHINYL ESTRADIOL | 94 |
| 9 | COPPER | 89 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AURANOFIN | 2 | 0.0098 |
| 1 | NINTEDANIB ESYLATE | 3 | 0.0086 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 18 | 0.0065 |
| 3 | ETONOGESTREL AND ETHINYL ESTRADIOL | 94 | 0.0042 |
| 4 | ANAKINRA | 56 | 0.0033 |
| 5 | DIFLUNISAL | 2 | 0.0025 |
| 6 | INFLIXIMAB-DYYB | 8 | 0.0023 |
| 7 | COPPER | 89 | 0.0021 |
| 8 | ERGOCALCIFEROL | 55 | 0.0018 |
| 9 | PRASTERONE | 5 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 338 |
| 1 | Progestin-containing Intrauterine System [EPC] | 227 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 171 |
| 3 | Estrogen [EPC] | 160 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 136 |
| 5 | Corticosteroid [EPC] | 130 |
| 6 | Vitamin C [EPC] | 120 |
| 7 | Vitamin D [EPC] | 120 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 110 |
| 9 | Vitamin B12 [EPC] | 105 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 56 | 0.0033 |
| 1 | Copper-containing Intrauterine Device [EPC] | 89 | 0.0018 |
| 2 | Progestin [EPC] | 338 | 0.0012 |
| 3 | Estrogen Agonist/Antagonist [EPC] | 3 | 0.0012 |
| 4 | Estrogen [EPC] | 160 | 0.0009 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 13 | 0.0007 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 53 | 0.0006 |
| 7 | Antirheumatic Agent [EPC] | 65 | 0.0006 |
| 8 | Aminosalicylate [EPC] | 61 | 0.0006 |
| 9 | Interferon alfa-2b [EPC] | 1 | 0.0005 |